Stable Incidence and Increasing Prevalence of Primary Hyperparathyroidism in a Population-based Study in Scotland
The Journal of Clinical Endocrinology & Metabolism · 18.09.2023 · 108 (10) · e1117-e1124
DOI: 10.1210/clinem/dgad201 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 06.04.2023. Verfasst von Enrique Soto-Pedre und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Population Health and Genomics, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK. Hauptthemen laut MEDLINE: Hyperparathyroidism, Primary. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHS Tayside Research Endowments.
Abstract (Originalsprache)
Context
Previous studies, including our own, have demonstrated a highly variable incidence of primary hyperparathyroidism (PHPT) from year to year.
Objective
We planned to provide a current estimate of the incidence and prevalence of PHPT in a community-based study.
Methods
A population-based retrospective follow-up study was conducted in Tayside (Scotland) from 2007 to 2018. Record-linkage technology (demography, biochemistry, prescribing, hospital admissions, radiology, and mortality data) was used to identify all patients. Cases of PHPT were defined as those with at least 2 raised serum corrected calcium concentration CCA (> 2.55 mmol/L) and/or hospital admissions with PHPT diagnoses and/or surgery records with parathyroidectomy during the follow-up period. The number of prevalent and incident cases of PHPT per calendar year by age and sex were estimated.
Results
A total of 2118 people (72.3% female, mean age 65 years) were identified with an incident case of PHPT. The overall prevalence of PHPT over the 12 years of the study was 0.84% (95% CI, 0.68%-1.02%), steadily increasing from 0.71% in 2007 to 1.02% in 2018. From 2008, the incidence of PHPT was relatively stable from 4 to 6 cases per 10 000 person-years, declining from 11.5 per 10 000 person-years in 2007. The incidence varied from 0.59 per 10 000 person-years (95% CI, 0.40%-0.77%) for those aged 20 to 29 years, to 12.4 per 10 000 person-years (95% CI, 11.2%-13.3%) in those aged 70 to 79 years. Incidence of PHPT was 2.5 times higher in women than in men.
Conclusion
This study is the first showing a relatively steady annual incidence of PHPT at 4 to 6 per 10 000 person-years. This population-based study reports a PHPT prevalence of 0.84%.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Population Health and Genomics, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK.
- Department of Endocrinology and Diabetes, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK.
- Division of Molecular and Clinical Medicine, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK.
ORCID-Profile: Enrique Soto-Pedre
Förderung
- NHS Tayside Research Endowments
Zitieren
APA
Soto-Pedre, E., Newey, P. J., & Leese, G. P. (2023). Stable Incidence and Increasing Prevalence of Primary Hyperparathyroidism in a Population-based Study in Scotland. The Journal of Clinical Endocrinology & Metabolism, 108(10), e1117-e1124. https://doi.org/10.1210/clinem/dgad201
Vancouver
Soto-Pedre E, Newey PJ, Leese GP. Stable Incidence and Increasing Prevalence of Primary Hyperparathyroidism in a Population-based Study in Scotland. The Journal of Clinical Endocrinology & Metabolism. 2023;108(10):e1117-e1124. doi:10.1210/clinem/dgad201
BibTeX
@article{SotoPedre2023,
author = {Soto-Pedre, Enrique and Newey, Paul J and Leese, Graham P},
title = {Stable Incidence and Increasing Prevalence of Primary Hyperparathyroidism in a Population-based Study in Scotland},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
volume = {108},
number = {10},
pages = {e1117--e1124},
doi = {10.1210/clinem/dgad201}
}
EUVIMED